ILMN

Illumina, Inc. News Headlines

$172
*  
0.09
0.05%
Get ILMN Alerts
*Delayed - data as of Aug. 22, 2014  -  Find a broker to begin trading ILMN now
Exchange: NASDAQ
Industry: Capital Goods
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Impairment Charge Hurts Illumina - Analyst Blog
7/25/2012 1:57:01 PM - Zacks.com

Affymetrix Upgraded to Neutral - Analyst Blog
7/2/2012 5:56:01 PM - Zacks.com

Life Tech Remains Neutral - Analyst Blog
6/28/2012 7:05:01 PM - Zacks.com

LIFE's Ion Suite Thrives on Tie-Ups - Analyst Blog
6/27/2012 3:11:20 PM - Zacks.com

Affymetrix Closes eBioscience Deal - Analyst Blog
6/26/2012 1:11:32 PM - Zacks.com

Qiagen Expands NGS Portfolio - Analyst Blog
6/26/2012 11:11:52 AM - Zacks.com

Illumina Unveils RapidTrack WGS - Analyst Blog
6/21/2012 11:45:01 AM - Zacks.com

LIFE Focuses on Stem Cell Research - Analyst Blog
6/20/2012 3:53:17 PM - Zacks.com

Life Expands AmpliSeq Portfolio - Analyst Blog
6/12/2012 2:34:01 AM - Zacks.com

Life Expands AmpliSeq Portfolio - Analyst Blog
6/11/2012 7:25:01 PM - Zacks.com

Affymetrix Teams Up with Leica - Analyst Blog
6/1/2012 4:30:28 PM - Zacks.com

Affymetrix Inks Distribution Pact - Analyst Blog
5/21/2012 7:27:01 PM - Zacks.com

GlaxoSmithKline to Get Hostile with Offer for Human Genome
5/9/2012 9:15:23 AM - Benzinga

Affymetrix Beats Ests., Posts Loss - Analyst Blog
5/8/2012 12:16:14 PM - Zacks.com

Genomic Health Beats Estimates - Analyst Blog
5/3/2012 12:49:17 PM - Zacks.com

Trader agrees Illumina is undervalued
4/24/2012 1:49:08 PM - optionMONSTER

Illumina Beats in 1Q - Analyst Blog
4/24/2012 10:50:04 AM - Zacks.com

Roche Stays Firm on Illumina Offer - Analyst Blog
4/19/2012 6:48:56 PM - Zacks.com

Roche's 1Q Sales Climb Up - Analyst Blog
4/13/2012 10:12:17 AM - Zacks.com

Roche Not Giving Up on Illumina - Analyst Blog
4/12/2012 10:00:01 AM - Zacks.com

Pre-Market Most Active for Apr 12, 2012 : NOK, BAC, RDS/A, UN, SNY, QRE, SIRI, QQQ, ILMN, ASML, AAPL, ORIG
4/12/2012 8:39:58 AM - NASDAQ.com News

Advisory Firms Back Illumina's View - Analyst Blog
4/9/2012 10:42:18 AM - Zacks.com

Roche-Illumina Saga Continues - Analyst Blog
4/9/2012 9:43:05 AM - Zacks.com

LIFE to Further Penetrate PGM Reach - Analyst Blog
4/5/2012 11:41:07 AM - Zacks.com

Zacks Bull and Bear of the Day Highlights: Zumiez, Dril-Quip, Roche Holdings, Illumina and Allstate - Press Releases
4/5/2012 9:30:01 AM - Zacks.com